US Patent Issued to Bzelet Health Systems on April 15 for "Cannabigerol (CBG) products and methods of use" (Minnesota, Maryland Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,727, issued on April 15, was assigned to Bzelet Health Systems Inc. (Orlando, Fla.).

"Cannabigerol (CBG) products and methods of use" was invented by Michael Elzufon (Maple Grove, Minn.) and Howard Hoffberg (Reisterstown, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A cannabinoid composition having antiinflammatory and antineoplastic activity, comprising a full spectrum extract of a plant of genus Cannabis comprising at least 5% by weight cannabigerol, comprising Cannabis terpenes and Cannabis flavonoids, and substantially without cannabidiol and tetrahydrocannabinol. The composition may be a pharmaceutically acceptable formulation for oral, su...